Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evaluate Launches Enhanced Orphan Drug Intelligence

Published: Monday, July 15, 2013
Last Updated: Monday, July 15, 2013
Bookmark and Share
Available to EvaluatePharma® service clients beginning June 20, 2013.

The worldwide orphan drug market is set to reach $127 billion by 2018, accounting for nearly 16 percent of total prescription drug sales, according to the recently released Orphan Drug Report 2013 from Evaluate.

To better serve its clients’ needs in regard to this growing segment of the pharmaceutical industry, Evaluate has enhanced its EvaluatePharma core product database to include in-depth, fact-based orphan drug analysis with data fields for integrated US, EU and Japan orphan drug designations.

The enhanced orphan drug content will be available to all EvaluatePharma service clients on June 20, 2013.

“As a company, we are focused on our clients’ success. This enhancement allows our clients to size and track the orphan drug market in order to make more informed, strategic decisions about portfolio strategy, growth opportunities and investments,” said Anthony Raeside, Head of Research at Evaluate.

EvaluatePharma has identified all products that have orphan drug designations filed in the US, EU or Japan, and has defined a clean ‘orphan’ sub-set of products through a fully transparent and documented methodology.

The new enhancement facilitates global analysis of the orphan drug R&D and commercial landscape - including the ability to:
• TRACK the orphan drug market via a transparent methodology
• MAKE orphan drug commercial assessments
• CONDUCT competitive intelligence including patent expiries and exclusivities
• SCREEN for orphan drug licensing opportunities by product, designation, indication
• BENCHMARK current and historical orphan drug deal terms and values
• IDENTIFY the future value of an orphan drug market via consensus sales forecasts
• KNOW the latest news and orphan drug designations and approvals


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Ancient Eggshell Protein Breaks Through DNA Time Barrier
Fossil proteins from a 3.8million year-old eggshell have been identifed, suggests proteins could give insight into evolutionary tree.
NCI Collaborates with Multiple Myeloma Research Foundation
NCI collaborates with MMRF to incorporate genomic and clinical data into NCI Genomic Data Commons database.
New Imaging Technique in Alzheimer’s Disease
Study confirms new imaging technique corresponds a higher degree of actual brain changes.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Antibiotic Resistance Can Occur Naturally in Soil Bacteria
Scientists have found natural anti-biotic resistant bacteria in soils with little to no human exposure.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!